ScitoVation logo
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote

Latest News

May 24, 2023

ScitoVation Recipient of National Institute of Environmental Health Science Small Business Innovation Research Phase II Award of $1.8 Million

Read More
Featured image for “A Source to Outcome Approach for Inhalation Risk Assessment: The Importance of Collaboration”
April 4, 2023

A Source to Outcome Approach for Inhalation Risk Assessment: The Importance of Collaboration

Read More
March 20, 2023

ScitoVation Announces Next Generation, Non-animal Genotoxicity Program

Read More
Featured image for “NAM-Driven Computational Pipelines for Safety and Regulatory Framework”
February 28, 2023

NAM-Driven Computational Pipelines for Safety and Regulatory Framework

Read More
Featured image for “Gene expression biomarkers as tools to interpret high-throughput transcriptomics data stream”
January 25, 2023

Gene expression biomarkers as tools to interpret high-throughput transcriptomics data stream

Read More
Featured image for “A revolution in mutagenicity testing: exploring the utility of error-corrected next-generation sequencing to quantify and characterize mutations”
November 8, 2022

A revolution in mutagenicity testing: exploring the utility of error-corrected next-generation sequencing to quantify and characterize mutations

Read More
Featured image for “New Approach Methodologies for Genetic Toxicity Assessment and Regulatory Evaluation of New and Existing Substances Description”
October 18, 2022

New Approach Methodologies for Genetic Toxicity Assessment and Regulatory Evaluation of New and Existing Substances Description

Read More
September 7, 2022

21st Century Respiratory Toxicology: Complex 3-dimensional Test Systems Provide Human-relevant Data and Will Benefit from Standardization Efforts

Read More
July 11, 2022

Andy Nong Joins ScitoVation as Director of Computational Toxicology

Read More
Prev 1 2 3 4 5 6 … 8 9 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2025 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote